Since the outbreak of the COVID-19 pandemic, "blood oxygen saturation" has gradually become a familiar term. Medically, blood oxygen levels reflect an individual's physical condition, and blood oxygen saturation (SpO2) serves as a crucial indicator of the circulatory and respiratory systems. It provides vital information for assessing overall health and detecting oxygen deficiency in the surrounding environment. Consequently, blood oxygen monitoring devices play a vital role in this invisible battle, offering rapid alerts when needed.

China Food and Drug News: On the afternoon of July 18, the Symposium on the Implementation of Medical Device Unique Identification (UDI), a key event of the 2022 National Medical Device Safety Awareness Week, was held in Beijing. The symposium was hosted by the Medical Device Registration Administration Department of the National Medical Products Administration (NMPA), with the Medical Device Standards Management Center and Information Center serving as co-organizers. A representative from NMPA's Medical Device Registration Administration Department delivered opening remarks. Representatives from medical device manufacturers, distributors, and healthcare institutions shared their experiences in implementing the Unique Device Identification (UDI) system. Provincial drug regulatory authorities presented updates on advancing UDI implementation within their respective regions. Additionally, NMPA's Information Center and Medical Device Standards Management Center provided updates on UDI database development, relevant standards, and ongoing technical research.